BRV China-backed HPC-AI Tech startup completes $6m seed and angel round financing

HPC-AI Tech, an artificial intelligence high-performance optimization startup announced the closing of $6 million seed and angel rounds, with BlueRun Ventures China (BRV China) acting as the lead investor for the angel round. The funds, which were raised within a year, will be mainly used to bring in more talented teams and expand the business market.

Founded in Beijing in 2021, HPC-AI Tech has established an overseas R&D center in Singapore and is focused on the enterprise AI market. Based on its deep experience and achievements in the industry, it has established Colossal-AI, an integrated large-scale model training system with efficient parallelization techniques. The system can accelerate model training on distributed systems with multiple GPUs by applying parallelization techniques. Colossal-AI efficiently promotes the application of large AI models on the ground and helps enterprises achieve low-cost AI intelligent solutions.

Jimmy Shi, Venture Partner, BRV China: "As an early-stage investor of HPC-AI Tech, BRV China is pleased to see that HPC-AI Tech has been recognized by many users in terms of its product development and global open source ecology. We expect the company to accelerate and deepen its ability to empower various industries with AI and grow into a globally renowned AI company." 

The Colossal-AI system, which has been open source for only a short time, has already received around 5,000 GitHub Stars, and been on the world's top GitHub Hotlist many times, with users all over the world. It has already established cooperation with a large number of well-known manufacturers and open source communities, covering the fields of autonomous driving, cloud computing, biotech, chip design, smart retail, etc.

Recently, HPC-AI Technology joined hands with BRV China's portfolio company BioMap, a startup biotech company, by creating the xTrimo Multimer open-source model to solve the difficulties of monomer and multimer structure prediction. The collaboration, an example of integration of technological innovation and vertical industries, shows how AI can help to accelerate the research and development of drugs.

Professor Yang You, Founder, HPC-AI Tech: "The digitalization and intelligent industrial transformation and upgrading of various industries are inseparable from the support of high-performance AI. Colossal-AI, a universal deep learning system in the era of large models, is the immediate need of the future AI market. Our solution can help enterprises and users effectively reduce the cost of AI big model training and inference, and empower the intelligent upgrade of the whole industry chain."

www.brv.com.cn
www.hpcaitech.com